NCT06272968View on ClinicalTrials.gov

Predicting Cognition After DBS for Parkinson's Disease 2

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2030

Conditions
Cognitive Impairment
Interventions
DIAGNOSTIC_TEST

Neuropsychological Testing

Neuropsychological Testing via Cambridge CANTAB Connect

Trial Locations (1)

13351

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT06272968 - Predicting Cognition After DBS for Parkinson's Disease 2 | Biotech Hunter | Biotech Hunter